These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 1658379)
1. Role of de novo protein synthesis in target cells recognized by cytotoxic T lymphocytes specific for vesicular stomatitis virus. Roscoe DM; Ishikawa K; Lyles DS J Virol; 1991 Dec; 65(12):6856-61. PubMed ID: 1658379 [TBL] [Abstract][Full Text] [Related]
2. Possible mechanisms by which the H-2Kbm3 mutation may decrease cytotoxic T-lymphocyte recognition of vesicular stomatitis virus nucleoprotein antigen. Bowman MR; Lyles DS; Parce JW J Virol; 1987 Jun; 61(6):1992-8. PubMed ID: 3033326 [TBL] [Abstract][Full Text] [Related]
3. Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes. Yewdell JW; Bennink JR; Mackett M; Lefrancois L; Lyles DS; Moss B J Exp Med; 1986 Jun; 163(6):1529-38. PubMed ID: 3011949 [TBL] [Abstract][Full Text] [Related]
4. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens. Browning MJ; Huang AS; Reiss CS J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651 [TBL] [Abstract][Full Text] [Related]
5. Use of DNA-mediated gene transfer to analyze the role of H-2Ld in controlling the specificity of anti-vesicular stomatitis virus cytotoxic T cells. Forman J; Goodenow RS; Hood L; Ciavarra R J Exp Med; 1983 Apr; 157(4):1261-72. PubMed ID: 6187888 [TBL] [Abstract][Full Text] [Related]
6. N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells. Puddington L; Bevan MJ; Rose JK; Lefrançois L J Virol; 1986 Nov; 60(2):708-17. PubMed ID: 3022003 [TBL] [Abstract][Full Text] [Related]
8. T helper cells in cytotoxic T lymphocyte development: role of L3T4(+)-dependent and -independent T helper cell pathways in virus-specific and alloreactive cytotoxic T lymphocyte responses. Ciavarra RP Cell Immunol; 1990 Feb; 125(2):363-79. PubMed ID: 2153464 [TBL] [Abstract][Full Text] [Related]
9. Lysis of target cells infected with vesicular stomatitis virus (VSV) in the presence of tunicamycin by anti-VSV cytotoxic T lymphocytes. Harris DT; Hale AH; Lefrancois L J Immunol; 1981 May; 126(5):1914-8. PubMed ID: 6260860 [TBL] [Abstract][Full Text] [Related]
10. Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells. Sheil JM; Bevan MJ; Lefrancois L J Immunol; 1987 Jun; 138(11):3654-60. PubMed ID: 3035010 [TBL] [Abstract][Full Text] [Related]
11. Antigen-presenting B cells: efficient uptake and presentation by activated B cells for induction of cytotoxic T lymphocytes against vesicular stomatitis virus. Ciavarra RP; Burgess DH Cell Immunol; 1988 Jun; 114(1):27-40. PubMed ID: 2836071 [TBL] [Abstract][Full Text] [Related]
12. The soluble viral glycoprotein of vesicular stomatitis virus efficiently sensitizes target cells for lysis by CD4+ T lymphocytes. Browning M; Reiss CS; Huang AS J Virol; 1990 Aug; 64(8):3810-6. PubMed ID: 2164598 [TBL] [Abstract][Full Text] [Related]
13. IFN-gamma-induced recognition of the antigen-processing variant CMT.64 by cytolytic T cells can be replaced by sequential addition of beta 2 microglobulin and antigenic peptides. Jefferies WA; Kolaitis G; Gabathuler R J Immunol; 1993 Sep; 151(6):2974-85. PubMed ID: 8397249 [TBL] [Abstract][Full Text] [Related]
14. In vivo CTL immunity can be elicited by in vitro reconstituted MHC/peptide complex. Sakita I; Hörig H; Sun R; Wang F; Nathenson SG J Immunol Methods; 1996 Jun; 192(1-2):105-15. PubMed ID: 8699005 [TBL] [Abstract][Full Text] [Related]
15. Specificity of in vitro cytotoxic T cell clones directed against vesicular stomatitis virus. Rosenthal KL; Oldstone MB; Hengartner H; Zinkernagel RM J Immunol; 1983 Jul; 131(1):475-8. PubMed ID: 6190924 [TBL] [Abstract][Full Text] [Related]
16. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product. Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201 [TBL] [Abstract][Full Text] [Related]
17. H-2L-restricted recognition of viral antigens In the H-2d haplotype, anti-vesicular stomatitis virus cytotoxic T cells are restricted solely by H-2L. Ciavarra R; Forman J J Exp Med; 1982 Sep; 156(3):778-90. PubMed ID: 6286837 [TBL] [Abstract][Full Text] [Related]
18. Immunization with recombinant protein: conditions for cytotoxic T cell and/or antibody induction. Bachmann MF; Hengartner H; Zinkernagel RM Med Microbiol Immunol; 1994 Dec; 183(6):315-24. PubMed ID: 7596314 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T lymphocytes reactive with vesicular stomatitis virus: analysis of specificity with monoclonal antibodies directed to the viral glycoprotein. Lefrancois L; Lyles DS J Immunol; 1983 Mar; 130(3):1408-12. PubMed ID: 6185583 [TBL] [Abstract][Full Text] [Related]
20. B7 costimulation is critical for antibody class switching and CD8(+) cytotoxic T-lymphocyte generation in the host response to vesicular stomatitis virus. McAdam AJ; Farkash EA; Gewurz BE; Sharpe AH J Virol; 2000 Jan; 74(1):203-8. PubMed ID: 10590107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]